×
Search your requirement
Search your requirement
Home
Press Releases
Submit Release
Events
Reach Us
Social media
Search
Home
Press Releases
Submit Release
Events
Reach Us
Search
MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing
Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics
Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season
OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award
Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis
ProJenX announces the formation of its Clinical Advisory Board
Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma
NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients
Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits
Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.
Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic
FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma
Featured Press Releases
CVS Pharmacy® announces new simplified loyalty experience
30% Lower Risk With WELIREG® + LENVIMA® vs. Cabozantinib in Previously Treated RCC
03 Mar 2026
Merck known as MSD outside of the United States and Canada, and Eisai today announced the first
...
BioCryst shares real-world data highlighting strong adherence and persistence with ORLADEYO® (berotralstat)
Chromatin Bioscience's synthetic promoter enables EsoBiotec's ESO-T01 CAR-T therapy to progress to clinical trials
MinuteClinic highlights improved access and outcomes through its clinically supervised weight-loss program
Rugiet Launched Physician-Prescribed Peptide and Longevity Therapies, Setting a New Standard in Performance Medicine
SEKISUI Diagnostics Announces 510(k) Clearance and Launches the OSOM® COVID-19/Flu A&B Combo Test
By
SEKISUI DIAGNOSTICS, LLC
SEKISUI DIAGNOSTICS, LLC
27 Oct 2026
Stevanato Group and Aptar Pharma Collaborate to Accelerate Pre-Filled Syringe System Selection
By
Stevanato Group S.p.A.
Stevanato Group S.p.A.
27 Oct 2026
Pythia Labs Launched AI-Designed Antibodies for Hard-to-Drug Targets
By
Pythia Labs
Pythia Labs
27 Oct 2026
Pythia Labs Launched AI-Designed Antibodies for Hard-to-Drug Targets
By
Pythia Labs
Pythia Labs
27 Oct 2026
MEPSGEN Launched NanoCalibur® Mini for Nanoparticle Formulation in Small Volumes
By
MEPSGEN US, Inc.
MEPSGEN US, Inc.
26 Oct 2026
Aptar Pharma Expands Next-Generation Pulmonary Drug Delivery Capabilities with Acquisition of Pulmotree
By
Aptar Pharma
Aptar Pharma
26 Oct 2026
Log in
Username
Show
Remember Me
Log in
Create an account
Forgot your username?
Forgot your password?
Most Popular
Hyalex Orthopaedics Reports Treatment of First Patients with Novel HYALEX® Knee Cartilage System
By
Hyalex Orthopaedics
Apr 23
Brain Navi’s KrystoLens Receives TFDA Certification and Is Set to Enter the Taiwan Market
By
Brain Navi Biotechnology
Jun 04
Immorta Bio Reports Successful Lung Cancer Growth Inhibition by Senolytic Immunotherapy SenoVax™
By
Immorta Bio Inc
Jun 12
October
2026
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
User Area
Login page
Registration
Edit Profile
Forgot Password
Discover
About Us
Terms Of Use
Privacy Policy
FAQs
Engage with Us
Search on Site
Post Press Release
Promote Brand
List Your Event
Subscribe to Our Monthly Newsletter
Subscribe to Pharmaceutical Era’s monthly newsletter,
Pharmaceutical Leaders Digest
®, to receive timely updates from across the pharmaceutical industry.
I agree with the
Terms and conditions
×
and the
Privacy policy
×
Please enable the javascript to submit this form
Subscribe
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. To find out more, please click
here
.
I understand
